Keywords: Cephalon, BioAssets, M&A, Etanercept, TNF

Cephalon pays $30 million option to acquire BioAssets Development Corp

Article | 26 October 2009

Print This

US privately-held Cephalon has signed an option agreement to acquire BioAssets Development Corp (BDC). Under the terms of the deal, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in